Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Parra, W. Teodoro, V. Capelozzi (São Paulo, Brazil). Arterial type V collagen disorganization in patients with systemic sclerosis: preliminary study. Eur Respir J 2007; 30: Suppl. 51, 542

Member's Comments

No comment yet.

Related content which might interest you: Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Up-regulation of collagen type V mRNA in a model of systemic sclerosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Tridimensional reconstruction and biochemical profile of collagen V alpha-2 chain in lung fibroblasts culture from patients with systemic sclerosis indicate a defect in fibrillogenesis microarchitecture Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Alveolar–capillary barrier alteration due to systemic sclerosis: an experimental study. Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Survival of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1393-1402 Year: 2015 Intravenous cyclophosphamide therapy for patients with interstitial pulmonary disease associated with collagen vascular disorders. A single-center experience Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Correlations of collagen matrix between nonspecific interstitial pneumonia and collagen disease - preliminary study Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 Is pulmonary arterial hypertension associated with interferon-ß therapy for multiple sclerosis reversible? A case study to explore the complexity Source: ERJ Open Res, 6 (1) 00328-2019; 10.1183/23120541.00328-2019 Year: 2020